As 5xFAD mice lack genetic alterations in VPS35 or other retromer components, our findings may be generalizable to sporadic AD cases, supporting the exploration of retromer-directed therapies as a potential disease-modifying strategy. This evidence concerns the gene VPS35 and Alzheimer disease.